Notice2022-02404
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 4, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Leptospirosis and Melioidosis Active Hospital-based Surveillance in Puerto Rico. The project aims to identify leptospirosis and melioidosis cases in Puerto Rico by establishing active surveillance for both diseases at four hospital sites for disease identification and treatment and to improve understanding of leptospirosis and melioidosis epidemiology and ecology in Puerto Rico for public health control and prevention planning.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 24 (Friday, February 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6554-6555]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02404]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-20MR; Docket No. CDC-2022-0018]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Leptospirosis and Melioidosis
Active Hospital-based Surveillance in Puerto Rico. The project aims to
identify leptospirosis and melioidosis cases in Puerto Rico by
establishing active surveillance for both diseases at four hospital
sites for disease identification and treatment and to improve
understanding of leptospirosis and melioidosis epidemiology and ecology
in Puerto Rico for public health control and prevention planning.
DATES: CDC must receive written comments on or before April 5, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0018 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#a6c9cbc4e6c5c2c588c1c9d0"><span class="__cf_email__" data-cfemail="2f40424d6f4c4b4c01484059">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Leptospirosis and Melioidosis Active Hospital-based Surveillance in
Puerto Rico--Existing Collection in Use Without an OMB Control Number--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This project aims to identify leptospirosis and melioidosis cases
in Puerto Rico by establishing active surveillance for both diseases at
four hospital sites for timely disease identification and treatment and
to improve understanding of leptospirosis and melioidosis epidemiology
and ecology in Puerto Rico for public health control and prevention
planning. Both diseases can cause outbreaks after hurricanes and
flooding, especially in tropical areas, and this project is being
conducted in response to an increase in leptospirosis cases after
Hurricanes Irma and Maria in 2017.
Participants will be recruited from the population presenting to
the emergency department of the four hospital sites with febrile
illness, and will be interviewed to gather information on symptoms,
possible exposures, and medical history, in addition to having
diagnostic samples collected to test for leptospirosis plus or minus
melioidosis (depending on presenting symptoms). Participants will also
be interviewed approximately two weeks after enrollment to determine
illness progression and outcome. Patients testing positive for
leptospirosis, if willing, may have animal samples taken from their
home or work environments to help determine the animal reservoirs
related to human leptospirosis illness in Puerto Rico.
CDC requests OMB approval for an estimated 1,675 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Patient...................... PIFA (screening) Up to 7,000.... 1 5/60 583
[[Page 6555]]
Patient...................... PIFA (full form: Up to 3,000.... 1 10/60 500
sections 1-4,
11).
Patient...................... Consent Form.... Up to 3,000.... 1 6/60 300
Patient...................... PIFF............ Up to 1,000.... 1 10/60 167
Patient...................... Animal Household Up to 250...... 1 30/60 125
Survey.
-----------------------------------------------
Total.................... ................ ............... .............. .............. 1,675
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02404 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.